LA BioMed Researchers may Have Developed Treatment for Mucormycosis

by Kathy Jones on  December 21, 2013 at 10:12 PM Research News
RSS Email Print This Page Comment
Font : A-A+

Researchers at Los Angeles Biomedical Research Institute (LA BioMed) have claimed that they have developed a way to prevent human cell invasion of Mucorales fungi and are able to treat mucormycosis in disease models using antibodies that block the CotH protein, a new study published in the Journal of Clinical Investigation reveals.
 LA BioMed Researchers may Have Developed Treatment for Mucormycosis
LA BioMed Researchers may Have Developed Treatment for Mucormycosis

"There are no vaccines or effective therapies available today to halt the highly fatal mucormycosis infection, and there is an urgent need for these strategies to protect patients with weakened immune systems," said Ashraf S. Ibrahim, PhD, an LA BioMed lead researcher and corresponding author for the study. "Our research lays the groundwork for developing the antibodies to prevent and treat mucormycosis in high-risk patients. These findings also could lead to diagnostic tests for the disease."

Patients with weakened immune systems, malnutrition or acidosis (hyperglycemia or diabetic ketoacidosis) are at increased risk of infection. Dr Ibrahim's group found treatment with anti-CotH antibodies or CotH-targeted RNAi blocked the cell invasion and protected against mucormycosis. In a commentary accompanying the research, J. Andrew Alspaugh, MD, professor, Department of Medicine, Division of Infectious Diseases at Duke University Medical Center, discusses how these findings could contribute to the development of mucormycosis therapies.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive